Field Medical Value & Outcomes Liaison

Pharmacosmos Therapeutics Inc.; Dallas (TX); Hybrid; USD 120,000 - 160,000; Full time

Job summary

Pharmacosmos Therapeutics Inc. invites an experienced Medical Value and Outcomes Liaison (MVOL) to advance scientific exchange and build strategic relationships with national population health decision makers and payor networks.

This field-based, non-promotional role translates health economics and real-world evidence into actionable insights for market access teams across community oncology, IDNs, IPPNs, GPOs and related stakeholders.

Qualifications

• Doctoral degree in health sciences or a Master’s in health sciences with relevant industry experience
• 2–3+ years in MSL, Market Access, Managed Care or HEOR/RWE
• Knowledge of the pharmaceutical landscape, managed care marketplace, hospital systems and care delivery
• Strong understanding of research methods, health economics and pharmacoeconomics
• Proven experience building KOL relationships with top medical experts
• Previous experience in Hematology/Oncology preferred
• Familiarity with PhRMA, OIG and ICH-GCP guidelines

Responsibilities

• Serve as a primary field medical lead to generate and execute scientific discussions with national accounts, IDNs, payors, and GPOs
• Develop KOL and PHDM relationships across account segments
• Contribute as a medical stakeholder to support HEOR/RWE data generation and budget impact models
• Identify HEOR/RWE data opportunities aligned with publication plans
• Collect insights to address treatment barriers and integration of PTI therapies in clinical pathways
• Enhance field medical reporting capabilities to quantify value of activities

Skills

Field medical leadership

Medical communications

Stakeholder engagement

Strategic thinking

Education

Doctoral or Master's in health sciences

Job description

Pharmacosmos Therapeutics Inc. invites an experienced Medical Value and Outcomes Liaison (MVOL) to advance scientific exchange and build strategic relationships with national population health decision makers and payor networks.

This field-based, non-promotional role translates health economics and real-world evidence into actionable insights for market access teams across community oncology, IDNs, IPPNs, GPOs and related stakeholders.